Web-based education to support mothers in their decision making about the HPV-vaccination of their daughter
- Conditions
- HPV, cervical cancer (HPV, baarmoederhalskanker)
- Registration Number
- NL-OMON29388
- Lead Sponsor
- TNOMaastricht University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 2400
Inclusion Criteria
Mothers/female caregivers of girls born in 2002.
Exclusion Criteria
- No mother/female caregiver of girls born in 2002
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HPV-vaccination uptake registered in Praeventis, the National Immunization Register in the Netherlands. Timepoint: 18 months after baseline (or earlier, as soon as the HPV-vaccination uptake of 2015 has been completed in Praeventis)
- Secondary Outcome Measures
Name Time Method Informed decision making of mothers and determinants of the HPV-vaccination acceptability (i.e., attitude, beliefs, subjective norms, anticipated regret, decisional conflict, habit and vaccination intention). Timepoint: 4 weeks after baseline.